The AGA report acknowledges that infection risk may be linked to the complexity of the scopes, a risk which remains despite proper reprocessing protocols. The AGA, along with its sister GI societies, is working with the FDA device branch and device manufacturers to solve the issue.
New FDA guidelines are expected this year.
More articles on gastroenterology:
11 gastroenterologists serving as ASC medical directors
FDA approves pacemaker-like device to treat obesity
Colorectal cancer mortality by tumor marker: 9 things to know
